|
Originally published In Press as doi:10.1074/jbc.M300547200 on May 15, 2003
J. Biol. Chem., Vol. 278, Issue 30, 27362-27371, July 25, 2003
Tumor Suppressor p53 and Its Homologue p73 Affect Cell Migration*,
Anna A. Sablina ,
Peter M. Chumakov ¶ || ** and
Boris P. Kopnin || 
From the
Lerner Research Institute, the Cleveland
Clinic Foundation, Cleveland, Ohio 44195,
Institute of Carcinogenesis, Russian Cancer
Research Center, Moscow, Russia 115478, and
¶Engelhardt Institute of Molecular Biology,
Moscow, Russia 119991
The p53 tumor suppressor plays a central role in the negative control of
growth and survival of abnormal cells. Previously we demonstrated that in
addition to these functions, p53 expression affects cell morphology and
lamellar activity of the cell edge (Alexandrova, A., Ivanov, A., Chumakov, P.
M., Kopnin, P. B., and Vasiliev, J. M. (2000) Oncogene 19,
58265830). In the present work we studied the effects of p53 and its
homologue p73 on cell migration. We found that loss of p53 function
correlated with decreased cell migration that was analyzed by in
vitro wound closure test and Boyden chamber assay. The decreased motility
of p53-deficient cells was observed in different cell contexts: human foreskin
fibroblasts (BJ), human colon and lung carcinoma cell lines (HCT116 and H1299,
respectively), as well as mouse normal fibroblasts from lung and spleen,
peritoneal macrophages, and keratinocytes. On the other hand, overexpression
of the p53 family member p73 stimulated cell migration. Changes in cell
migration correlated directly with transcription activation induced by p53 or
p73 . Noteworthy, p53 modulated cell motility in the absence of stress.
The effect of p53 and p73 on cell migration was mediated through the
activity of the phosphatidylinositol 3-kinase/Rac1 pathway. This p53/p73
function was mainly associated with some modulation of intracellular signaling
rather than with stimulation of production of secreted motogenic factors. The
identified novel activity of the p53 family members might be involved in
regulation of embryogenesis, wound healing, or inflammatory response.
Received for publication, January 17, 2003
, and in revised form, May 13, 2003.
* This work was supported by startup funds from the Lerner Research Institute
(to P. M. C.), the International Research Scholars Program of the Howard
Hughes Medical Institute (to B. P. K.), and the Russian Foundation for Basic
Research (to A. A. S., P. M. C., and B. P. K.). The costs of publication of
this article were defrayed in part by the payment of page charges. This
article must therefore be hereby marked "advertisement"
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at
http://www.jbc.org)
contains Figs. 1-7.
|| Both senior authors contributed equally to this work.
**
To whom correspondence may be addressed. Tel.: 216-444-9540; E-mail:
chumakp{at}ccf.org.

To whom correspondence may be addressed. Tel.: 7-095-324-1739; E-mail:
bkopnin{at}yahoo.com.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Sato, M. B. Vaughan, L. Girard, M. Peyton, W. Lee, D. S. Shames, R. D. Ramirez, N. Sunaga, A. F. Gazdar, J. W. Shay, et al.
Multiple Oncogenic Changes (K-RASV12, p53 Knockdown, Mutant EGFRs, p16 Bypass, Telomerase) Are Not Sufficient to Confer a Full Malignant Phenotype on Human Bronchial Epithelial Cells
Cancer Res.,
February 15, 2006;
66(4):
2116 - 2128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Fan, J. R. Harrell, S. Dipp, Z. Saifudeen, and S. S. El-Dahr
A novel pathological role of p53 in kidney development revealed by gene-environment interactions
Am J Physiol Renal Physiol,
January 1, 2005;
288(1):
F98 - F107.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|